Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 2
1(33.3%)
3Total
N/A(2)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT03750617Not ApplicableUnknown

Web-Mediated Risk Assessment for Endoscopic Screening of Colorectal Polyps

Role: lead

NCT03484949Not ApplicableUnknown

Web-Mediated Risk Assessment for Endoscopic Screening of Gastric Cancer

Role: lead

NCT02215642Unknown

Nutrition and Lifestyle Study Cohort of Colorectal Cancer in China

Role: lead

NCT02216955Unknown

Nutrition and Lifestyle Study Cohort of Gastric Cancer in China

Role: lead

NCT01196260Phase 2Unknown

Combination Chemotherapy Treatments in Patients With Colorectal Cancer Stage II and III

Role: lead

NCT02222753Unknown

Immunological Markers Screening for Colorectal Cancer

Role: lead

All 6 trials loaded